COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability.

It's hard to believe it's been five years since the start of COVID-19. This timeline serves as a reminder of those early days ...

VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.

Study uncovers the evolution, transmission, and geographic spread of bat coronaviruses in China, revealing key insights into ...

Wen: The majority of people with diarrhea, vomiting and stomach cramps have viral gastroenteritis caused by the very ...

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

The COVID pandemic is ongoing, but scientists are on alert for any pathogen that might lead to another global outbreak of ...

New data shared by British Columbia's Centre for Disease Control shows the province has one of the worst flu rates in Canada, ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

After a relatively slow start to the respiratory virus season, Covid-19 levels in the United States began ramping up just ...

Donald Trump reportedly intends to seal off the US-Mexican border by invoking a public health emergency. The ...